NCT06081699View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

September 18, 2019

Study Completion Date

September 18, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

TNP-2198

Oral

DRUG

TNP-2198 Placebo

The placebo for TNP-2198 active drug

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

TenNor Therapeutics (Suzhou) Limited

INDUSTRY

NCT06081699 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants | Biotech Hunter | Biotech Hunter